Literature DB >> 33268842

Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.

Wenqi Yang1,2, Ling Liu2, Yuan Wei1,2, Chunlu Fang1,2, Shujing Liu1,2, Fu Zhou2, Yaping Li2, Ge Zhao2, Ziyi Guo2, Yuan Luo2, Liangming Li3,4.   

Abstract

NLRP3 inflammasome activation, which can be triggered by reactive oxygen species (ROS), contributes to nonalcoholic steatohepatitis (NASH) progression. Exercise is an effective therapeutic strategy for NASH. However, whether exercise prevents NLRP3 activation in NASH has not been investigated. Here, we investigated the effect of exercise on NLRP3 inflammasome in mice with high-fat diet (HFD)-induced or methionine and choine-deficient (MCD) diet-induced NASH and explored whether adropin, a metabolic peptide hormone shown to inhibit inflammation, mediates an exercise-induced benefit against NLRP3 inflammasome activation. Exercise alleviated diet-induced hepatic steatosis, inflammation, and fibrosis. Importantly, exercise significantly reduced the expression of NLRP3 inflammasome components, decreased Caspase-1 enzymatic activity, normalized IL-1β production, and suppressed ROS overproduction in HFD-fed and MCD diet-fed mice. The exercise-elicited NLRP3 inflammasome inhibition was accompanied by increased adropin levels. Moreover, serum adropin levels were negatively correlated with serum IL-1β levels. We further explored the effect of adropin on the NLRP3 inflammasome in palmitic acid (PA)-treated hepatocytes and Kupffer cells. Although adropin treatment did not significantly decrease the levels of all inflammasome components, it reduced the active Caspase-1 level, decreased Caspase-1 activity and downregulated IL-1β expression in hepatocytes and Kupffer cells (KCs) treated with PA. Moreover, ROS levels in PA-stimulated hepatocytes and Kupffer cells were reduced upon adropin treatment. In summary, we demonstrated that the inhibitory effect of exercise on NLRP3 inflammasome activation was associated with adropin induction, resulting in NASH improvement.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33268842     DOI: 10.1038/s41374-020-00508-y

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  45 in total

Review 1.  NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.

Authors:  Alena Grebe; Florian Hoss; Eicke Latz
Journal:  Circ Res       Date:  2018-06-08       Impact factor: 17.367

Review 2.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

3.  Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease.

Authors:  Christopher J A Pugh; Daniel J Cuthbertson; Victoria S Sprung; Graham J Kemp; Paul Richardson; A Margot Umpleby; Daniel J Green; N Timothy Cable; Helen Jones
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-07       Impact factor: 4.310

Review 4.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

Review 5.  Therapeutic Landscape for NAFLD in 2020.

Authors:  Brent A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  2020-02-13       Impact factor: 22.682

Review 6.  Nonalcoholic fatty liver disease: pathology and pathogenesis.

Authors:  Dina G Tiniakos; Miriam B Vos; Elizabeth M Brunt
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 7.  Nonalcoholic Steatohepatitis: A Review.

Authors:  Adam C Sheka; Oyedele Adeyi; Julie Thompson; Bilal Hameed; Peter A Crawford; Sayeed Ikramuddin
Journal:  JAMA       Date:  2020-03-24       Impact factor: 56.272

8.  NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.

Authors:  Auvro R Mridha; Alexander Wree; Avril A B Robertson; Matthew M Yeh; Casey D Johnson; Derrick M Van Rooyen; Fahrettin Haczeyni; Narci C-H Teoh; Christopher Savard; George N Ioannou; Seth L Masters; Kate Schroder; Matthew A Cooper; Ariel E Feldstein; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2017-02-03       Impact factor: 25.083

9.  Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits.

Authors:  Duck-Pil Ok; Kangeun Ko; Ju Yong Bae
Journal:  Lipids Health Dis       Date:  2018-09-01       Impact factor: 3.876

Review 10.  Toward targeting inflammasomes: insights into their regulation and activation.

Authors:  Shelbi Christgen; David E Place; Thirumala-Devi Kanneganti
Journal:  Cell Res       Date:  2020-03-09       Impact factor: 25.617

View more
  1 in total

1.  Tai Chi as a Therapy of Traditional Chinese Medicine on Reducing Blood Pressure: A Systematic Review of Randomized Controlled Trials.

Authors:  Xiandu Pan; Li Tian; Fan Yang; Jiahao Sun; Xinye Li; Na An; Yanfen Xing; Xin Su; Xu Liu; Can Liu; Yonghong Gao; Yanwei Xing
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-04       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.